How Many Units Is 2.5 mg of Tirzepatide?

Mounjaro KwikPen delivers a fixed dose: the UK-licensed device is pre-filled and pre-set; you press the button and it delivers exactly 2.5 mg without any measurement on your part.
The 'units' calculation is concentration-dependent: 2.5 mg equals 20 units only at 1 mg/mL, a different concentration gives a completely different unit number, which is why converting units without knowing the exact preparation is dangerous.
2.5 mg is a tolerability dose: the first pen in the licensed Mounjaro schedule exists to let your body adjust gradually, not to deliver the full therapeutic effect.
Dose changes are a clinical decision: when to move to 5 mg and beyond is decided by a prescriber reviewing your progress, not by a calculator or an online chart.

2.5 mg of tirzepatide is 20 units when drawn from a vial at the standard 1 mg/mL concentration used in compounded preparations, but this figure does not apply to the UK-licensed Mounjaro KwikPen, which delivers a fixed, pre-measured dose — no syringe, no unit counting, no measuring required. If you are using the licensed Mounjaro pen in the UK, your prescriber selects the dose; the device delivers it automatically, and the concept of 'units' is not relevant to how you use it. The question tends to arise when people come across information about compounded or reconstituted tirzepatide preparations, often from US sources, so it is worth understanding exactly what applies here in the UK — and what does not.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the 'units' question is really asking, and why the answer matters in the UK

Where the 20-unit figure comes from

The conversion that produces 20 units for a 2.5 mg dose of tirzepatide is straightforward arithmetic: if a vial is prepared at a concentration of 1 mg per millilitre, then 2.5 mg occupies 2.5 mL of fluid. Since an insulin syringe typically reads in units of 0.01 mL each (meaning 100 units equals 1 mL) 2.5 mL works out to 250 units on that scale. But most compounded tirzepatide preparations circulating online are formulated at much higher concentrations, for example 5 mg/mL or 10 mg/mL, which would make 2.5 mg just 50 units or 25 units respectively. There is no single universal answer, which is precisely the problem. The MHRA has warned publicly about unlicensed compounded tirzepatide pens being seized across the UK, including the first illicit domestic manufacturing site raided in Northampton in October 2025; a calculation drawn from a US forum or a compounding pharmacy's label has no safe application to an unverified preparation.

The BNF entry for tirzepatide and the NHS medicines information page for tirzepatide both describe the drug in terms of milligrams, not units, because the licensed UK product requires no conversion. Worth keeping that in mind before going down a unit-counting rabbit hole based on international content.

How the licensed Mounjaro KwikPen actually works

The Mounjaro KwikPen is a pre-filled, disposable device designed so that patients never need to handle a syringe or measure anything. Each pen contains enough solution for four weekly injections. You dial to confirm you are ready (depending on the pen's instructions) attach the needle, and inject. The pen stops delivering when the correct volume has been expelled. The 2.5 mg pen delivers 2.5 mg. That is the end of the maths.

The licensed schedule, described factually in the BNF's tirzepatide entry, starts at 2.5 mg for the first four weeks. This opening period is about settling the digestive system rather than driving significant weight loss; nausea and other gastrointestinal effects are most likely to occur at the start, and the low starting dose is designed to reduce their impact. The prescriber then reviews progress and decides when (and whether) to increase to 5 mg. People sometimes wonder whether staying on 2.5 mg longer would help if side effects are mild; that is a conversation to have directly with a clinician, not something to resolve by adjusting units on a syringe.

If you are curious about what the next step looks like in practice, the 5 mg Mounjaro dose page covers the transition in more detail.

Why unit conversions for tirzepatide carry real risk

People arrive at the units question from different starting points. Some have switched from insulin, where drawing up specific units is second nature. Others have encountered compounded tirzepatide on social media, often from US sources where pharmacy-compounded versions were available during periods of branded shortage. A third group are trying to understand whether a vial they have been offered is the right dose.

Each of these situations carries a distinct risk. Compounded tirzepatide is not licensed in the UK. Concentration varies between batches and between suppliers. A miscalculation of even one decimal place (say, drawing 2.5 units rather than 25) could deliver a tenth of the intended dose; the reverse error could be dangerous. The MHRA's guidance on GLP-1 medicines makes clear that these are prescription-only medicines requiring clinical assessment, and that sellers offering them without going through a registered prescriber and a GPhC-registered pharmacy are operating outside the law. If you are thinking about the cost of treatment alongside these questions, our Mounjaro price comparison page sets out the UK private market context honestly, including what a legitimate price should cover.

It is also worth knowing how to check whether a pharmacy is properly registered. The GPhC register lets you search any online pharmacy by name or registration number before handing over a prescription or payment.

Dose conversions at other strengths

The same concentration-dependence applies across the full Mounjaro range. If you want to understand how units map onto the 5 mg or 7.5 mg doses in the context of non-licensed preparations (for example, to make sense of information you have already come across) the pages covering how many units is 5 mg of tirzepatide and how many units is 7.5 mg of tirzepatide walk through the arithmetic the same way this page does, including the concentration caveats. There are also pages on what 30 units of tirzepatide equals in milligrams and what 60 units equals if you are working backwards from a unit figure someone has given you.

Every conversion on those pages carries the same core message: unit numbers are only meaningful alongside the specific concentration of the preparation in question. For the UK-licensed Mounjaro pen, that question simply does not arise. Your prescriber and the device handle it. If you are at the point of thinking about starting treatment (or wondering whether 2.5 mg is where you would begin) speaking to our prescribers is the practical next step.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions